Patents by Inventor Robert Turner

Robert Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210230537
    Abstract: Provided herein are stimulated placental stem cells and methods of treating individuals having diseases or disorders of the circulatory system using stimulated placental cells. The invention also provides methods of inducing angiogenesis using such stimulated cells or populations of cells comprising such stimulated cells.
    Type: Application
    Filed: January 7, 2021
    Publication date: July 29, 2021
    Applicant: Celularity Inc.
    Inventors: Kathy E. KARASIEWICZ-MENDEZ, Aleksander FRANCKI, Jeffrey TURNER, Eric LAW, Jennifer PAREDES, Kristen LABAZZO, Hemlata RANA, Wolfgang HOFGARTNER, Robert J. HARIRI
  • Publication number: 20210232699
    Abstract: A breach detection engine detects and mitigates the effects of breaches across one or more data sources. An index is generated based on one or more data sources and the index is queried using keywords indicative of potential breaches. A database of potential breaches is populated based on the query of the index. The potential breach database is queried using keywords associated with a system identity (e.g., a third party). A likelihood of a candidate breach is identified based on a set of breach criteria weights. A network node associated with a candidate breach determined to be an actual breach is identified for isolation or for the performance of one or more additional security actions.
    Type: Application
    Filed: April 15, 2021
    Publication date: July 29, 2021
    Inventors: Alan James Sharp-Paul, Christopher Robert Vickery, Jonathan David Hendren, Gregory Ford Pollock, Daniel Bradbury, Christian Alan Kiely, Gavin Richard Turner, Michael Franz Baukes
  • Patent number: 11055402
    Abstract: A method is provided for safely executing dynamically generated code to avoid the possibility of an attack in unprotected memory space. Upon ascertaining that dynamically generated code is to be executed, a processing circuit and/or operating system kernel restrict the dynamically generated code to use a first memory region within an unprotected memory space, where the first memory region is distinct (e.g., reserved) from other memory regions used by other processes executed by the processing circuit. A first processing stack is maintained for the dynamically generated code within the first memory region. This first processing stack is separate from a general processing stack used by other processes executed by the processing circuit. A stack pointer is switched/pointed to the first processing stack when the dynamically generated code is executed and the stack pointer is switched/pointed to the general processing stack when the dynamically generated code ends.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: July 6, 2021
    Assignee: QUALCOMM Incorporated
    Inventors: Can Acar, Robert Turner, Alexander Gantman
  • Publication number: 20210171527
    Abstract: The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Application
    Filed: January 18, 2017
    Publication date: June 10, 2021
    Inventors: Delphine COLLIN, Johanna CSENGERY, Robert Owen HUGHES, Michael Robert TURNER, Lifen WU
  • Publication number: 20210163449
    Abstract: The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 3, 2021
    Applicants: Boehringer Ingelheim International GmbH, Hydra Biosciences, LLC
    Inventors: Thierry Bouyssou, Dirk Gottschling, Niklas Heine, Lana Louise Smith Keenan, Michael D. Lowe, Hossein Razavi, Christopher Ronald Sarko, Simon Surprenant, Hidenori Takahashi, Michael Robert Turner, Xinyuan Wu
  • Patent number: 11000056
    Abstract: The present invention provides bioactive serum fractions and bioactive extracts derived from an Achachairu (Garcinia humilis) plant. The bioactive serum fractions and bioactive extracts are free of or substantially free of benzophenone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making the bioactive serum fractions and/or bioactive extracts.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: May 11, 2021
    Assignee: ISP Investments LLC
    Inventors: Olga Dueva-Koganov, Michael Koganov, Paul Recht, Artyom Duev, Li Zhang, Steven Micceri, Robert Turner
  • Publication number: 20210130302
    Abstract: The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
    Type: Application
    Filed: September 24, 2020
    Publication date: May 6, 2021
    Inventors: Zef KONST, Yipin LU, Robert Joseph MOREAU, Naomi Samadara RAJAPAKSA, Galen SHEARN-NANCE, David Charles TULLY, Michael Robert TURNER, Joseph Michael YOUNG, Qian ZHAO, Britton K. CORKEY, Samuel E. METOBO
  • Publication number: 20210080019
    Abstract: A closure mechanism and a method for plugging a flow control device of a well is provided. The closure mechanism includes a switch having a hollow interior and a U-shaped portion. The closure mechanism also includes a metal insert located within a portion of the hollow interior of the switch. The mechanism further includes a heating device positioned within the well. In the method, the heating device is activated in the well and melts at least a portion of the metal insert. The melted portion of the metal insert collects and re-solidifies within the U-shaped portion of the switch, thereby closing the switch and plugging the flow control device against flow.
    Type: Application
    Filed: September 18, 2019
    Publication date: March 18, 2021
    Inventors: Brett Bouldin, Kenechukwu Ufondu, Robert Turner
  • Publication number: 20210020275
    Abstract: Systems, devices, media, methods, and kits are disclosed to integrate and exchange information of analyte analysis kits. Analyte analysis can be performed and presented using in association with advertising or questions.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Rajaram KRISHNAN, Iryna CLARK, Robert TURNER, Robert KOVELMAN, Juan Pablo HINESTROSA SALAZAR, David LIU
  • Patent number: 10889568
    Abstract: The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: January 12, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thierry Bouyssou, Dirk Gottschling, Niklas Heine, Lana Louise Smith Keenan, Michael D. Lowe, Hossein Razavi, Christopher Ronald Sarko, Simon Surprenant, Hidenori Takahashi, Michael Robert Turner, Xinyuan Wu
  • Patent number: 10883810
    Abstract: Provided in some embodiments is a well torpedo system that includes a torpedo adapted to be advanced in a wellbore of a subterranean well. The torpedo including an integrated spool adapted to hold a fiber-optic (FO) umbilical including a FO line adapted to couple to a surface component, and an engine adapted to combust solid propellant to generate thrust to propel advancement of the torpedo in the wellbore.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: January 5, 2021
    Assignee: Saudi Arabian Oil Company
    Inventors: Brett Bouldin, Robert Turner, Ahmed Bukhamseen, Andrey Bakulin, Michael Jervis
  • Publication number: 20200401685
    Abstract: A computerized system for associating RF signals, the system including at least one sensor configured to sense a plurality of RF signals at at least a plurality of points in time and a computerized associator receiving outputs from the at least one sensor and providing an output which associates at least some of the plurality of RF signals with at least one unique multiple RF signal-based identifier.
    Type: Application
    Filed: August 31, 2020
    Publication date: December 24, 2020
    Inventors: Aaron Robert Turner, Robert Michael McMillon, II
  • Publication number: 20200399282
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts therefore, wherein R1 to R6, A, U, V, W, X, Y, and Z are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Application
    Filed: February 13, 2019
    Publication date: December 24, 2020
    Inventors: Steven Brunette, Jianwen Cui, Michael D. Lowe, Christopher Ronald Sarko, Simon Surprenant, Michael Robert Turner, Xinyuan Wu, Lana Louise Smith Keenan, Thierry Bouyssou, Paul Nicklin
  • Publication number: 20200340791
    Abstract: Provided in some embodiments is a well torpedo system that includes a torpedo adapted to be advanced in a wellbore of a subterranean well. The torpedo including an integrated spool adapted to hold a fiber-optic (FO) umbilical including a FO line adapted to couple to a surface component, and an engine adapted to combust solid propellant to generate thrust to propel advancement of the torpedo in the wellbore.
    Type: Application
    Filed: April 24, 2019
    Publication date: October 29, 2020
    Inventors: Brett Bouldin, Robert Turner, Ahmed Bukhamseen, Andrey Bakulin, Michael Jervis
  • Patent number: 10818379
    Abstract: Systems, devices, media, methods, and kits are disclosed to integrate and exchange information of analyte analysis kits. Analyte analysis can be performed and presented using in association with advertising or questions.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: October 27, 2020
    Assignee: BIOLOGICAL DYNAMICS, INC.
    Inventors: Rajaram Krishnan, Iryna Clark, Robert Turner, Robert Kovelman, Juan Pablo Hinestrosa Salazar, David Liu
  • Patent number: 10800757
    Abstract: The invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R1 to R7, A, Y and L are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: October 13, 2020
    Assignees: Boehringer Ingelheim International GmbH, Hydra Biosciences, LLC
    Inventors: Thierry Bouyssou, Dirk Gottschling, Niklas Heine, Lana Louise Smith Keenan, Michael D. Lowe, Hossein Razavi, Christopher Ronald Sarko, Simon Surprenant, Hidenori Takahashi, Michael Robert Turner, Xinyuan Wu
  • Patent number: 10789350
    Abstract: A computerized system for associating RF signals, the system including at least one sensor configured to sense a plurality of RF signals at at least a plurality of points in time and a computerized associator receiving outputs from the at least one sensor and providing an output which associates at least some of the plurality of RF signals with at least one unique multiple RF signal-based identifier.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: September 29, 2020
    Assignee: VeriFone, Inc.
    Inventors: Aaron Robert Turner, Robert Michael McMillon, II
  • Patent number: 10707696
    Abstract: The present invention provides a method for operation of an offline uninterrupted power supplyfor providing power to a load in case of failure of a power source, the uninterrupted power supply comprising at least one disconnect switch, which is arranged between the power source and the load, at least one energy storage, at least one power converter, which is arranged between the at least one energy storage and the load at a load side of the disconnect switch, and a control device for controlling the at least one power converter to provide power from the at least one energy storage to the load in case of failure of the power source, comprising the steps of identifying a power quality event, differentiating the identified power quality events to separate load side events from power supply side quality events, and upon identification of a power supply side power quality event from an identified power quality event, providing power from the at least one energy storage to the load.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: July 7, 2020
    Assignee: ABB Schweiz AG
    Inventors: Sridhar Pulikanti, Simon James Walton, Robert Turner, NIck Elliott
  • Patent number: 10624882
    Abstract: Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: April 21, 2020
    Assignee: Aerie Pharmaceuticals, Inc.
    Inventors: Todd Bosanac, John David Ginn, Eugene Richard Hickey, Thomas Martin Kirrane, Jr., Weimin Liu, Anthony S. Prokopowicz, Sabine K. Schlyer, Cheng-Kon Shih, Roger John Snow, Michael Robert Turner, Frank Wu, Erick Richard Young
  • Patent number: 10594555
    Abstract: A system and method for testing a control system is disclosed. The control system includes a field device located in one area and a controller located in a different area. A mobile application running on a mobile computing device is used by a technician to test the control system. Because both the mobile computing device and the controller are coupled to a cloud computing system, the technician may interface with the controller while located at the field device. This remote access to the controller allows a single technician to test the control system by interfacing with the controller and the field device simultaneously. In addition, the mobile application may retrieve data from the cloud computing system to facilitate testing and may transmit test results to the cloud for storage. Others having access to the stored results may view the progress and results of the testing.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: March 17, 2020
    Assignee: INTELLIGENT PLATFORMS, LLC
    Inventors: Keith George McNab, Robert Turner